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cumstances to assist the Agency’s determination of device safety
and effectiveness. One example is left ventricular assist device
(LVAD) therapy for end-stage heart failure. METHODS: Clini-
cal trials conducted in support of LVAD regulatory approval
have demonstrated mortality beneﬁts compared to optimal
medical therapy alone. However, signiﬁcant adverse events are
also typically observed, including sepsis, bleeding and stroke.
The regulatory challenge is to determine an acceptable tradeoff
between mortality and adverse events. In this regard, PRO’s
including quality of life measures could provide additional infor-
mation to assist in decision-making for device approval and 
also guide development of a more informative product label.
RESULTS: Three issues need to be addressed to boost the scien-
tiﬁc validity of PRO’s in heart failure device trials: 1) the inher-
ent unblinded study design for such devices makes PRO’s
susceptible to patient bias, confounding study results; 2) differ-
ential rates of follow-up between treatment arms: patients too
moribund to complete follow-up assessment tools might lead to
underreporting of negative HRQOL data and confound study
results; and 3) a consensus needs to be achieved regarding the
selection of valid assessment tools for heart failure studies. CON-
CLUSIONS: PRO’s have promise in heart failure device evalua-
tion, however, several important issues need to be addressed to
properly incorporate such measures in studies intended for reg-
ulatory approval. The FDA welcomes dialogue with the clinical,
academic and industry communities to develop appropriate PRO
measures for heart failure device therapy.
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OBJECTIVES: To predict students’ academic achievement (GPA)
by Self-efﬁcacy (SE). SE is deﬁned as the self-perception that one
can master a certain task or perform adequately in a given situ-
ation. METHODS: A descriptive cross-sectional survey was
employed for studying the relationship between Self-efﬁcacy and
academic achievement (GPA) of all (178) 5th year pharmacy stu-
dents at The College of Pharmacy, Chulalongkorn University,
Bangkok, Thailand during the period of August to September,
2003. RESULTS: The ﬁnal return rate of questionnaire was 171
(96.06%). The respondents average age was 22.02 years. Most
(124) were female (72.51%). The reliability coefﬁcient (Cron-
bach’s alpha) of Self-Efﬁcacy (SE) scale was 0.87. The ﬁndings
showed that there was positive relationship between SE and aca-
demic achievement (GPA) r = 0.38 (p = 0.03). The length of time
for preparing for an examination by a female was longer than
for a male (p = 0.03). There was no difference between male and
female SE (p = 0.07). However, female’s GPA was signiﬁcantly
higher than male’s (p = 0.02). SE of the Bangkoker students was
not different form the Non-Bangkoker students (p = 0.87). Stu-
dents who participated in activities had higher SE than students
who did not (p = 0.24) but the GPA of the two groups was not
different (p = 0.59). Attitude toward pharmacy profession had
no impact on SE nor GPA (p = 0.78, 0.82). The three predictors
of the model were SE, Gender, and Time (to prepare the exam-
ination) R square = 0.40, beta = 0.38, 0.10, and 0.07 (p = 0.02).
IQ was not controlled in this study. CONCLUSIONS: Self-Efﬁ-
cacy was a good predictor of academic achievement of Chula-
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OBJECTIVES: High Body Mass Index (BMI) and obesity, preva-
lent throughout industrialised societies, are known to be associ-
ated with many co-morbidities. A possible increase in upper
respiratory tract infections (URTI) associated with higher BMI
was investigated in this study. METHODS: Cohort study using
prospectively recorded patient data within the Full Feature
General Practice Research Database (GPRD) which represents
approximately 5% of UK population. Study subjects were cate-
gorised according to their baseline BMI into ﬁve exposure
groups: I 18.5–24.9; II 25.0–29.9; III 30.0–34.9; IV 35.0–39.9
and V 40.0 and above. BMI records of 50.0 and over were 
discarded. Patients were followed from January 1, 1998 until
December 31, 2002. Study outcomes were either Ear Nose and
Throat (ENT) infections, or Respiratory Tract Infections (RTI).
Statistical analysis: For each outcome group, crude incidence
rates and incidence rate ratios (IRR) by BMI category were esti-
mated. Poison regression analysis was used to make adjustments
for age, gender, asthma, COPD, diabetes, smoking status, GP
consultations and sleep apnoea. RESULTS: A total of 244,479
patients were eligible for the cohort. The adjusted IRR for ENT
infections and URTI respectively was for BMI group II, 1.13
(1.11, 1.15) and 1.10 (1.08, 1.12), for BMI group III, 1.18 (1.15,
1.21) and 1.21 (1.17, 1.24) BMI group IV, 1.23 (1.17, 1.28) and
1.33 (1.27, 1.39) and for BMI group V 1.29 (1.20, 1.38) and
1.42 (1.32, 1.53). These ﬁndings were consistent after stratiﬁca-
tion by the number of GP consultations in 1997. CONCLU-
SIONS: This study provides evidence that there is an association
between increasing BMI and ENT and upper respiratory tract
infection. This association should be taken into consideration in
the evaluation of the burden of obesity.
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OBJECTIVE: In Italy, the most recent report for the National
Institute of Statistics (ISTAT) indicate that 1/3 of Italians are
overweight an 1/10 obese, making the problem less dramatic
than in the UK, Germany or USA. The objectives of this prospec-
tive naturalistic study were to describe direct and indirect costs
attributable to the management of overweight and obesity and
to identify factors associated with costs of management of 
subjects with overweight and obese. METHODS: The study
included subjects between 18–65 years old with a body mass
index greater than 25 (BMI, deﬁned as weight in kilograms
divided by the square of height in meters). Our estimates of the
direct Health Care costs for the Italian National Health Care
Service (I-Nhs) refer to 399 subjects enrolled at 52 centers and
show a signiﬁcant increase in total and I-Nhs monthly costs with
increasing BMI. RESULTS: The increase in the average total
monthly costs between overweight (82€), mild (189€), moderate
(197€) and severe (233€) obese subjects was borderline signiﬁ-
cant (P = 0.051, Kruskall Wallis test). The increase in the average
